Cargando…

Aberrant CXCR4 and β-catenin expression in osteosarcoma correlates with patient survival

To determine the clinical significance of C-X-C chemokine receptor type 4 (CXCR4) and β-catenin in osteosarcoma, their protein expression levels were assessed in 96 osteosarcoma and 20 osteochondroma cases using immunohistochemistry. Additionally, CXCR4 and β-catenin mRNA expression levels were meas...

Descripción completa

Detalles Bibliográficos
Autores principales:	LU, YAO, GUAN, GUO-FENG, CHEN, JIE, HU, BIN, SUN, CONG, MA, QIONG, WEN, YAN-HUA, QIU, XIU-CHUN, ZHOU, YONG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579913/ https://www.ncbi.nlm.nih.gov/pubmed/26622806 http://dx.doi.org/10.3892/ol.2015.3535

Ejemplares similares

Aberrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorigenicity
por: YI, XI-JUN, et al.
Publicado: (2015)

Defective CFTR leads to aberrant β-catenin activation and kidney fibrosis
por: Zhang, Jie Ting, et al.
Publicado: (2017)

Aberrant Expression of β-Catenin Correlates with Infiltrating Immune Cells and Prognosis in NSCLC
por: Zheng, Hongmei, et al.
Publicado: (2021)

CXCR4-targeted near-infrared imaging allows detection of orthotopic and metastatic human osteosarcoma in a mouse model
por: Guan, Guofeng, et al.
Publicado: (2015)

CXCR3 from chemokine receptor family correlates with immune infiltration and predicts poor survival in osteosarcoma
por: Tang, Yin, et al.
Publicado: (2019)

Aberrant ADAM10 expression correlates with osteosarcoma progression
por: Zhao, Ren, et al.
Publicado: (2014)

Aberrant Activation of the WNT/β-Catenin Signaling Pathway in Lupus Nephritis
por: Wang, Xiao-dong, et al.
Publicado: (2014)

Aberrant WNT/β-catenin signaling in parathyroid carcinoma
por: Svedlund, Jessica, et al.
Publicado: (2010)

Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity
por: Lozano, Elisa, et al.
Publicado: (2023)

CXCR4 induces podocyte injury and proteinuria by activating β-catenin signaling
por: Mo, Hongyan, et al.
Publicado: (2022)

Targeting the Wnt/β-catenin pathway in human osteosarcoma cells
por: Fang, Fang, et al.
Publicado: (2018)

Wnt/β-Catenin Expression Does Not Correlate with Serum Alkaline Phosphatase Concentration in Canine Osteosarcoma Patients
por: Piskun, Caroline M., et al.
Publicado: (2011)

Aberrant nuclear localization of β-catenin without genetic alterations in β-catenin or Axin genes in esophageal cancer
por: Kudo, Junzo, et al.
Publicado: (2007)

Phytochemicals Attenuating Aberrant Activation of β-Catenin in Cancer Cells
por: Wang, Dan, et al.
Publicado: (2012)

FOXO1 inhibits osteosarcoma oncogenesis via Wnt/β-catenin pathway suppression
por: Guan, H, et al.
Publicado: (2015)

CXCR7-mediated progression of osteosarcoma in the lungs
por: Goguet-Surmenian, E, et al.
Publicado: (2013)

Aberrant activation of Wnt/β-catenin signaling drives proliferation of bone sarcoma cells
por: Chen, Changbao, et al.
Publicado: (2015)

FAM83H is involved in stabilization of β-catenin and progression of osteosarcomas
por: Kim, Kyoung Min, et al.
Publicado: (2019)

Prognostic Significance of β-Catenin Expression in Osteosarcoma: A Meta-Analysis
por: Xie, Xiaoliang, et al.
Publicado: (2020)

MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling
por: Guan, Han, et al.
Publicado: (2017)

β-Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis
por: Saegusa, M, et al.
Publicado: (2001)

CXCR4 in human osteosarcoma malignant progression. The response of osteosarcoma cell lines to the fully human CXCR4 antibody MDX1338
por: Pollino, Serena, et al.
Publicado: (2019)

Wnt/β-catenin signaling modulates piperine-mediated antitumor effects on human osteosarcoma cells
por: Qi, Yu-Bin, et al.
Publicado: (2020)

Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway
por: Ma, Yunlong, et al.
Publicado: (2015)

Loss of β-arrestin-2 and Activation of CXCR2 Correlate with Lymph Node Metastasis in Non-small Cell Lung Cancer
por: Cong, Lei, et al.
Publicado: (2017)

CD44 expression is correlated with osteosarcoma cell progression and immune infiltration and affects the Wnt/β-catenin signaling pathway
por: Ji, Hairu, et al.
Publicado: (2023)

miR-135b Stimulates Osteosarcoma Recurrence and Lung Metastasis via Notch and Wnt/β-Catenin Signaling
por: Jin, Hua, et al.
Publicado: (2017)

Upregulated TC1 and downregulated Chibby were correlated with the aberrant β-catenin expression in laryngeal squamous cell carcinoma
por: Ren, Gang, et al.
Publicado: (2023)

Isoquercitrin restrains the proliferation and promotes apoptosis of human osteosarcoma cells by inhibiting the Wnt/β-catenin pathway
por: Wei, Zhun, et al.
Publicado: (2023)

KIF18B promotes tumor progression in osteosarcoma by activating β-catenin
por: Gao, Tian, et al.
Publicado: (2020)

iNOS Promotes the Development of Osteosarcoma via Wnt/β-Catenin Pathway
por: Chu, Wei, et al.
Publicado: (2021)

Hypoxia Promotes Migration and Induces CXCR4 Expression via HIF-1α Activation in Human Osteosarcoma
por: Guo, Mingjun, et al.
Publicado: (2014)

Targeting LncRNA-MALAT1 suppresses the progression of osteosarcoma by altering the expression and localization of β-catenin
por: Zhang, Zhi-Chang, et al.
Publicado: (2018)

CXCL1/CXCR2 Paracrine Axis Contributes to Lung Metastasis in Osteosarcoma
por: Chao, Chia-Chia, et al.
Publicado: (2020)

Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients
por: Lee, Sang-Jeon, et al.
Publicado: (2013)

VAMP8 suppresses the metastasis via DDX5/β-catenin signal pathway in osteosarcoma
por: Yang, Shuo, et al.
Publicado: (2023)

Correlation between the expression of vegf and survival in osteosarcoma
por: Baptista, André Mathias, et al.
Publicado: (2014)

Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin
por: Shimozaki, Shingo, et al.
Publicado: (2016)

Osteosarcoma progression is associated with increased nuclear levels and transcriptional activity of activated β-Catenin
por: Ali, Noureen, et al.
Publicado: (2019)

Dihydrotanshinone I inhibits the growth of osteosarcoma through the Wnt/β-catenin signaling pathway
por: Tan, Tao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cf3u1l5d2q2aumec98tamsobil